Page last updated: 2024-08-23

phenyl acetate and Coronary Thrombosis

phenyl acetate has been researched along with Coronary Thrombosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antrilli, TM; Crandall, DL; Elokdah, H; Friedrichs, GS; Hennan, JK; Hreha, A; Ji, A; Leal, M; Morgan, GA; Swillo, RE1
Hornberger, W; Kirchengast, M; Rübsamen, K1
Fitzgerald, DJ; Murphy, NP; Pratico, D1

Other Studies

3 other study(ies) available for phenyl acetate and Coronary Thrombosis

ArticleYear
Evaluation of PAI-039 [{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid], a novel plasminogen activator inhibitor-1 inhibitor, in a canine model of coronary artery thrombosis.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 314, Issue:2

    Topics: Acetates; Animals; Bleeding Time; Blood Pressure; Coronary Circulation; Coronary Thrombosis; Dogs; Endpoint Determination; Fibrinolysis; Fibrinolytic Agents; Heart Rate; Hemostasis; Indoleacetic Acids; Indoles; Partial Thromboplastin Time; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Ventricular Remodeling

2005
Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Thrombosis and haemostasis, 1995, Volume: 74, Issue:5

    Topics: Acetates; Ancrod; Animals; Antithrombins; Benzamides; Coronary Thrombosis; Dogs; Female; Fibrinolytic Agents; Hemodynamics; Hirudins; Male; Platelet Glycoprotein GPIIb-IIIa Complex

1995
Functional relevance of the expression of ligand-induced binding sites in the response to platelet GP IIb/IIIa antagonists in vivo.
    The Journal of pharmacology and experimental therapeutics, 1998, Volume: 286, Issue:2

    Topics: Acetates; Animals; Binding Sites; Blood Platelets; Coronary Thrombosis; Dogs; Fibrinolytic Agents; Hemorrhage; Oligopeptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reperfusion Injury; Thromboxane B2; Tissue Plasminogen Activator; Tyrosine

1998